glp 1 trump administration Unveils Plan to Make GLP-1 Drugs Affordable Trump says Medicare, Medicaid won't
Description
As impressive as todays GLP-1 therapies are, I can assure you that what lies in the foreground whether you think of it as the Learjet or Gulfstream equivalent will likely deliver superior performance to what weve been applauding up to this point. In a previous article, I shared insights from the workshop on the pressures created by soaring demand and where the market might go next
Good communication
Doyle TG, Wen C, Greenwald I
[17] In November 2025, Pfizer won a bidding war with Novo Nordisk, acquiring obesity drug developer, Metsera
[DOI] [PubMed] [Google Scholar] 38.Reutens A
